Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02249026

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:13.548076+00:00

Published At

2016-05-06T00:00:00+00:00

Record Updated At

2016-05-06

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Drug; Withdrawal Symptoms, Neonatal", "Withdrawal", "Fetus and Newborn Affected by Other Maternal Medication"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2016-05-06"

protocolSection.identificationModule.nctId

"NCT02249026"

protocolSection.identificationModule.officialTitle

"Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Drug; Withdrawal Symptoms, Neonatal (protocolSection.conditionsModule.conditions)
• Withdrawal (protocolSection.conditionsModule.conditions)
• Fetus and Newborn Affected by Other Maternal Medication (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.